Showing results (271-280 of 352) with videos related to
Sort By:
Pageof 36
American Journal of Hematology|August 25, 2015
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decadeTalha Badar, Hagop M Kantarjian, Graciela M Nogueras-Gonzalez, et al.Diabetes Care|September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS StudyJohn B Buse, M Angelyn Bethel, Jennifer B Green, et al.Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.Blood Cancer Journal|May 6, 2020
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemiaIman Abou Dalle, Ahmad Ghorab, Keyur Patel, et al.The American Journal of Surgical Pathology|June 19, 2013
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 casesEric Y Loo, L Jeffrey Medeiros, Tariq N Aladily, et al.Circulation. Cardiovascular Quality and Outcomes|September 15, 2017
Association Between Living in Food Deserts and Cardiovascular RiskHeval M Kelli, Muhammad Hammadah, Hina Ahmed, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.Cancer|October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agentsElias Jabbour, Stefan Faderl, Koji Sasaki, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2017
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral TherapyIra M Jacobson, Mary K Washington, Maria Buti, et al.Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.Pageof 36